18 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
26 Apr 23
Additional proxy soliciting materials
4:38pm
for diversity and inclusion to drive innovation. His work has helped to solidify the foundation from which we will continue to build for the future
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
26 Apr 23
Bristol Myers Squibb Announces Leadership Transition Plan
4:35pm
and champion for diversity and inclusion to drive innovation. His work has helped to solidify the foundation from which we will continue to build
DEFA14A
BMY
Bristol-Myers Squibb Co.
10 Apr 23
Additional proxy soliciting materials
5:12pm
& safety Cultivating diversity, equity & inclusion Ensuring health equity, patient access & innovation Social 2021 ≥ 25% new clinical trial sites
8-K
EX-99.3
BMY
Bristol-Myers Squibb Co.
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
product quality & safety Cultivating diversity, equity & inclusion Ensuring health equity, patient access & innovation
DEFA14A
xdzbg
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.3
5ru1n9pg64n8ih o24eu
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
8-K
EX-99.1
zym27x7sr 8rzck
29 Apr 21
Bristol Myers Squibb Reports First Quarter Financial Results for 2021
8:38am
DEFA14A
bc5wrc
19 Apr 21
Additional proxy soliciting materials
7:41am
8-K
EX-99.1
p0fch a5uwqi
4 Feb 21
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020
8:04am
8-K
EX-99.1
4pb2af
5 Nov 20
Bristol Myers Squibb Reports Third Quarter 2020 Financial Results
8:10am
425
4fbwglxfm1t1 k0g0
31 Jan 19
Business combination disclosure
12:00am
- Prev
- 1
- Next